Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology

Olga Zolochevska, Nicole Bjorklund, Randall (Randy) Woltjer, John E. Wiktorowicz, Giulio Taglialatela

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Some individuals, here referred to as Non-Demented with Alzheimer's Neuropathology (NDAN), retain their cognitive function despite the presence of amyloid plaques and tau tangles typical of symptomatic Alzheimer's disease (AD). In NDAN, unlike AD, toxic amyloid-β oligomers do not localize to the postsynaptic densities (PSDs). Synaptic resistance to amyloid-β in NDAN may thus enable these individuals to remain cognitively intact despite the AD-like pathology. The mechanism(s) responsible for this resistance remains unresolved and understanding such protective biological processes could reveal novel targets for the development of effective treatments for AD. The present study uses a proteomic approach to compare the hippocampal postsynaptic densities of NDAN, AD, and healthy age-matched persons to identify protein signatures characteristic for these groups. Subcellular fractionation followed by 2D gel electrophoresis and mass spectrometry were used to analyze the PSDs. We describe fifteen proteins which comprise the unique proteomic signature of NDAN PSDs, thus setting them apart from control subjects and AD patients.

Original languageEnglish (US)
Pages (from-to)659-682
Number of pages24
JournalJournal of Alzheimer's disease : JAD
Volume65
Issue number2
DOIs
StatePublished - Jan 1 2018

Fingerprint

Proteome
Post-Synaptic Density
Alzheimer Disease
Amyloid
Proteomics
Biological Phenomena
Poisons
Amyloid Plaques
Electrophoresis, Gel, Two-Dimensional
Cognition
Neuropathology
Mass Spectrometry
Proteins
Pathology

Keywords

  • Alzheimer’s disease
  • non-demented with AD-like pathology
  • postsynaptic density proteome
  • synapse

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology. / Zolochevska, Olga; Bjorklund, Nicole; Woltjer, Randall (Randy); Wiktorowicz, John E.; Taglialatela, Giulio.

In: Journal of Alzheimer's disease : JAD, Vol. 65, No. 2, 01.01.2018, p. 659-682.

Research output: Contribution to journalArticle

Zolochevska, Olga ; Bjorklund, Nicole ; Woltjer, Randall (Randy) ; Wiktorowicz, John E. ; Taglialatela, Giulio. / Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology. In: Journal of Alzheimer's disease : JAD. 2018 ; Vol. 65, No. 2. pp. 659-682.
@article{92722a7cd30749699259eb339bfcf5a2,
title = "Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology",
abstract = "Some individuals, here referred to as Non-Demented with Alzheimer's Neuropathology (NDAN), retain their cognitive function despite the presence of amyloid plaques and tau tangles typical of symptomatic Alzheimer's disease (AD). In NDAN, unlike AD, toxic amyloid-β oligomers do not localize to the postsynaptic densities (PSDs). Synaptic resistance to amyloid-β in NDAN may thus enable these individuals to remain cognitively intact despite the AD-like pathology. The mechanism(s) responsible for this resistance remains unresolved and understanding such protective biological processes could reveal novel targets for the development of effective treatments for AD. The present study uses a proteomic approach to compare the hippocampal postsynaptic densities of NDAN, AD, and healthy age-matched persons to identify protein signatures characteristic for these groups. Subcellular fractionation followed by 2D gel electrophoresis and mass spectrometry were used to analyze the PSDs. We describe fifteen proteins which comprise the unique proteomic signature of NDAN PSDs, thus setting them apart from control subjects and AD patients.",
keywords = "Alzheimer’s disease, non-demented with AD-like pathology, postsynaptic density proteome, synapse",
author = "Olga Zolochevska and Nicole Bjorklund and Woltjer, {Randall (Randy)} and Wiktorowicz, {John E.} and Giulio Taglialatela",
year = "2018",
month = "1",
day = "1",
doi = "10.3233/JAD-180179",
language = "English (US)",
volume = "65",
pages = "659--682",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology

AU - Zolochevska, Olga

AU - Bjorklund, Nicole

AU - Woltjer, Randall (Randy)

AU - Wiktorowicz, John E.

AU - Taglialatela, Giulio

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Some individuals, here referred to as Non-Demented with Alzheimer's Neuropathology (NDAN), retain their cognitive function despite the presence of amyloid plaques and tau tangles typical of symptomatic Alzheimer's disease (AD). In NDAN, unlike AD, toxic amyloid-β oligomers do not localize to the postsynaptic densities (PSDs). Synaptic resistance to amyloid-β in NDAN may thus enable these individuals to remain cognitively intact despite the AD-like pathology. The mechanism(s) responsible for this resistance remains unresolved and understanding such protective biological processes could reveal novel targets for the development of effective treatments for AD. The present study uses a proteomic approach to compare the hippocampal postsynaptic densities of NDAN, AD, and healthy age-matched persons to identify protein signatures characteristic for these groups. Subcellular fractionation followed by 2D gel electrophoresis and mass spectrometry were used to analyze the PSDs. We describe fifteen proteins which comprise the unique proteomic signature of NDAN PSDs, thus setting them apart from control subjects and AD patients.

AB - Some individuals, here referred to as Non-Demented with Alzheimer's Neuropathology (NDAN), retain their cognitive function despite the presence of amyloid plaques and tau tangles typical of symptomatic Alzheimer's disease (AD). In NDAN, unlike AD, toxic amyloid-β oligomers do not localize to the postsynaptic densities (PSDs). Synaptic resistance to amyloid-β in NDAN may thus enable these individuals to remain cognitively intact despite the AD-like pathology. The mechanism(s) responsible for this resistance remains unresolved and understanding such protective biological processes could reveal novel targets for the development of effective treatments for AD. The present study uses a proteomic approach to compare the hippocampal postsynaptic densities of NDAN, AD, and healthy age-matched persons to identify protein signatures characteristic for these groups. Subcellular fractionation followed by 2D gel electrophoresis and mass spectrometry were used to analyze the PSDs. We describe fifteen proteins which comprise the unique proteomic signature of NDAN PSDs, thus setting them apart from control subjects and AD patients.

KW - Alzheimer’s disease

KW - non-demented with AD-like pathology

KW - postsynaptic density proteome

KW - synapse

UR - http://www.scopus.com/inward/record.url?scp=85062884163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062884163&partnerID=8YFLogxK

U2 - 10.3233/JAD-180179

DO - 10.3233/JAD-180179

M3 - Article

VL - 65

SP - 659

EP - 682

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 2

ER -